On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Robert Bosch Gesellschaft Fur Medizinische Forschung Mbh's own share of each project, not the project's full budget.
- Horizon 2020€5.7M · 4 projects
- FP7 (2007 to 2013)€2.7M · 7 projects
- Horizon Europe€654k · 1 project
Projects
12 EU-funded projects, newest first. Robert Bosch Gesellschaft Fur Medizinische Forschung Mbh led 1 of them as coordinator. Each links to the official record.
- NEMESISPartner
Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS
Horizon Europe · 2024–2028 · Project on CORDIS ↗
€654ktheir share - MOBILISE-DPartner
Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€2.4Mtheir share - c4cPartner
conect4children (COllaborative Network for European Clinical Trials For Children)
Horizon 2020 · 2018–2025 · Project on CORDIS ↗
€2.0Mtheir share - U-PGxPartner
Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen
Horizon 2020 · 2016–2021 · Project on CORDIS ↗
€561ktheir share - PreventITPartner
Early risk detection and prevention in ageing people by self-administered ICT-supported assessment and a behavioural change intervention delivered by use of smartphones and smartwatches
Horizon 2020 · 2016–2019 · Project on CORDIS ↗
€665ktheir share - DEFENSINACTIVITYPartner
The influence of environmental factors on antimicrobial activity of human intestinal defensins
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€367ktheir share - FARSEEINGPartner
FAll Repository for the design of Smart and sElf-adaptive Environments prolonging INdependent livinG
FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗
€532ktheir share - PREDECTPartner
New Models for Preclinical Evaluation of Drug Efficacy in Common Solid Tumours
FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗
€340ktheir share - ANTIRESDEVPartner
The effects of antibiotic administration on the emergence and persistence of antibiotic-resistant bacteria in humans and on the composition of the indigenous microbiotas at various body sites
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€60ktheir share - FIGHTINGDRUGFAILURECoordinator
Priorities and Standards in Pharmacogenomic Research: Opportunities for a Safer and More Efficient Pharmacotherapy
FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗
€1.3Mtheir share - NEUROSISPartner
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
FP7 (2007 to 2013) · 2009–2015 · Project on CORDIS ↗
€87ktheir share - KINACEPTPartner
Novel anti-inflammatory compounds for autoimmune diseases
FP7 (2007 to 2013) · 2008–2010 · Project on CORDIS ↗
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Ecole Polytechnique Federale de LausanneSwitzerland · 4 shared projects
- Karolinska InstitutetSweden · 4 shared projects
- Eberhard Karls Universitaet TuebingenGermany · 4 shared projects
- Alma Mater Studiorum - Universita di BolognaItaly · 3 shared projects
- Norges Teknisk-Naturvitenskapelige Universitet NTNUNorway · 3 shared projects
- Aristotelio Panepistimio ThessalonikisGreece · 3 shared projects
- The University of LiverpoolUnited Kingdom · 3 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Stichting Radboud UniversiteitNetherlands · 2 shared projects
- The University of ManchesterUnited Kingdom · 2 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 2 shared projects
- University of Newcastle Upon TyneUnited Kingdom · 2 shared projects
- Tartu UlikoolEstonia · 2 shared projects
- Univerza V LjubljaniSlovenia · 2 shared projects
- Friedrich-Alexander-Universitaet Erlangen-NuernbergGermany · 2 shared projects
- Oulun YliopistoFinland · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- adverse drug reactions
- antibiotic resistance
- antibiotics
- arteriosclerosis
- autoimmune diseases
- bacteriology
- big data
- biomolecules
- bioreactors
- business models
- data protection
- databases
- drug discovery
- health economics
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
